BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9278890)

  • 1. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Biomed Anal; 1997 Aug; 15(12):1851-9. PubMed ID: 9278890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of a sustained-release biodegradable pellet containing imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Tagawa K; Murata K; Banno K; Sato T
    J Pharm Biomed Anal; 1997 Aug; 15(12):1861-6. PubMed ID: 9278891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
    Hosoya K; Ishimitsu T
    Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
    Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
    J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
    Harder S; Thürmann PA
    Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats.
    Sasaki Y; Noguchi T; Seki J; Giddings JC; Yamamoto J
    Thromb Haemost; 2000 May; 83(5):722-7. PubMed ID: 10823269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function.
    Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
    Eur J Clin Pharmacol; 1997; 51(6):489-91. PubMed ID: 9112065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human.
    Tagawa K; Mizobe M; Noda K
    Biol Pharm Bull; 1995 Jan; 18(1):64-9. PubMed ID: 7735253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril.
    Tsuruoka S; Kitoh Y; Kawaguchi A; Sugimoto K; Hayasaka T; Saito T; Fujimura A
    J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure.
    Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
    Eur J Clin Pharmacol; 1998 Mar; 54(1):59-61. PubMed ID: 9591932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].
    Hashimoto Y; Kubo M; Sugaya T; Minobe S; Watanabe T; Yamamura M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):51-61. PubMed ID: 8076891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
    Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
    J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective action of angiotensin converting enzyme inhibitors on cardiac hypertrophy in the aortic-banded rat.
    Kurosawa Y; Kojima K; Kato M; Ohashi R; Minami K; Narita H
    Jpn Heart J; 1999 Sep; 40(5):645-54. PubMed ID: 10888384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No relation of the suppressive effect on the sympathetic nervous system to the acute hypotension caused by imidapril and enalapril.
    Ogiku N; Sumikawa H; Ishida R
    Jpn J Pharmacol; 1993 Nov; 63(3):295-303. PubMed ID: 7906318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidapril, an angiotensin-converting enzyme inhibitor, inhibits thrombosis via reduction in aortic plasminogen activator inhibitor type-1 levels in spontaneously hypertensive rats.
    Mitsui T; Chishima S; Odawara A; Ohtani A
    Biol Pharm Bull; 1999 Aug; 22(8):863-5. PubMed ID: 10480327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Mabuchi M; Kano Y; Fukuyama T; Kondo T
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):145-53. PubMed ID: 10574200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of an angiotensin-converting-enzyme inhibitor, imidapril, and Ca2+ channel antagonist, amlodipine, in spontaneously hypertensive rats at established stage of hypertension.
    Yokota S; Naito Y; Yoshida H; Ohara N; Adachi T; Narita H
    Jpn J Pharmacol; 1998 May; 77(1):79-87. PubMed ID: 9639063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.